Revital
Revital Barelly, Petah Tikva IL
Patent application number | Description | Published |
---|---|---|
20130144137 | METHOD AND SYSTEM FOR NON-INVASIVELY MONITORING BIOLOGICAL OR BIOCHEMICAL PARAMETERS OF INDIVIDUAL - A system and method are presented for use in monitoring one or more conditions of a subject's body. The system includes a control unit which includes an input port for receiving image data, a memory utility, and a processor utility. The image data is indicative of data measured by a pixel detector array and is in the form of a sequence of speckle patterns generated by a portion of the subject's body in response to illumination thereof by coherent light according to a certain sampling time pattern. The memory utility stores one or more predetermined models, the model comprising data indicative of a relation between one or more measurable parameters and one or more conditions of the subject's body. The processor utility is configured and operable for processing the image data to determine one or more corresponding body conditions; and generating output data indicative of the corresponding body conditions. | 06-06-2013 |
Revital Eres, Tel-Aviv IL
Patent application number | Description | Published |
---|---|---|
20130138922 | REGISTER MANAGEMENT IN AN EXTENDED PROCESSOR ARCHITECTURE - Systems and methods are disclosed for enhancing the throughput of a processor by minimizing the number of transfers of data associated with data transfer between a register file and a memory stack. The register file used by a processor running an application is partitioned into a number of blocks. A subset of the blocks of the register file is defined in an application binary interface enabling the subset to be pre-allocated and exposed to the application binary interface. Optionally, blocks other than the subset are not exposed to the application binary interface so that the data relating to application function switch or a context switch is not transferred between the unexposed blocks and a memory stack. | 05-30-2013 |
Revital Etzyoni, Kfar-Saba IL
Patent application number | Description | Published |
---|---|---|
20150141458 | Treatment of Glaucoma Using Laquinimod - The subject invention provides a method of treating a subject afflicted with glaucoma, suffering from retinal ganglion cell (RGC) loss or damage, or elevated intraocular pressure (IOP), or of reducing RGC loss or damage, or reducing IOP in a subject, comprising administering to the subject an amount of laquinimod effective to treat the subject, to reduce RGC loss or damage, or to reduce IOP in the subject. Provide also is a pharmaceutical composition, a package and a therapeutic package for treating a subject afflicted with glaucoma. | 05-21-2015 |
Revital Lifshitz-Liron, Hertzlia IL
Patent application number | Description | Published |
---|---|---|
20090012047 | Crystalline forms of ibandronate sodium - Provided are crystalline forms of ibandronate sodium, as well as processes for the preparation thereof. | 01-08-2009 |
20090018182 | Crystalline forms of atorvastatin - Novel forms of atorvastatin hemi-calcium have been prepared and characterized. These novel forms are particularly useful in pharmaceutical compositions. | 01-15-2009 |
20090023949 | Amorphous ibandronic acid - Amorphous ibandronic acid is provided with methods for its preparation. The methods include dissolution of ibandronic acid in a solvent such as acetonitrile, DMSO, methanol, or water, and spray drying. | 01-22-2009 |
20090069581 | PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES - The present invention provides processes and intermediates for the synthesis of ramelteon. | 03-12-2009 |
20090069598 | Solid and crystalline ibandronic acid - Provided are novel crystalline forms of ibandronic acid, physical data, methods for their preparation, and uses therefor. Also provided are methods for purifying and assaying ibandronic acid in any crystalline form. | 03-12-2009 |
20090105490 | Polymorphic forms of ramelteon and processes for preparation thereof - An amorphous form of ramelteon is provided, as well as mixtures of amorphous and crystalline ramelteon. Also provided are methods of preparing amorphous ramelteon and mixtures of amorphous and crystalline ramelteon, pharmaceutical compositions comprising amorphous ramelteon and mixtures of amorphous and crystalline ramelteon, and methods of treatment of insomnia using the compositions of the invention. | 04-23-2009 |
Revital Mandil-Levin, Ness Ziona IL
Patent application number | Description | Published |
---|---|---|
20150065432 | VISFATIN THERAPEUTIC AGENTS FOR THE TREATMENT OF ACNE AND OTHER CONDITIONS - The present disclosure relates to compositions and methods for treating acne and other conditions. In particular, the compositions and methods are useful for the treatment of sebum associated conditions. | 03-05-2015 |
Revital Mandil-Levin, Rishon Lezion IL
Patent application number | Description | Published |
---|---|---|
20100215634 | VISFATIN THERAPEUTIC AGENTS FOR THE TREATMENT OF ACNE AND OTHER CONDITIONS - The present disclosure relates to compositions and methods for treating acne and other conditions. In particular, the compositions and methods are useful for the treatment of sebum associated conditions. | 08-26-2010 |
Revital Perry-Shechter, Rishon Lezion IL
Patent application number | Description | Published |
---|---|---|
20080296514 | SYSTEM AND METHOD FOR NONINVASIVELY MONITORING CONDITIONS OF A SUBJECT - A method and system are presented for use in determining one or more parameters of a subject. A region of interest of the subject is irradiated with acoustic tagging radiation, which comprises at least one acoustic tagging beam. At least a portion of the region of interest is irradiated with at least one electromagnetic beam of a predetermined frequency range. Electromagnetic radiation response of the at least portion of the region of interest is detected and measured data indicative thereof is generated. The detected response comprises electromagnetic radiation tagged by the acoustic radiation. This enables processing of the measured data indicative of the detected electromagnetic radiation response to determine at least one parameter of the subject in a region corresponding to the locations in the medium at which the electromagnetic radiation has been tagged by the acoustic radiation, and outputting data indicative of the at least one determined parameter. | 12-04-2008 |
Revital Pery-Schechter, Rishon Lezion IL
Patent application number | Description | Published |
---|---|---|
20120184830 | METHOD AND APPARATUS FOR NONINVASIVELY MONITORING PARAMETERS OF A REGION OF INTEREST IN A HUMAN BODY - Apparatus and methods are provided for monitoring a parameter of a region of interest (ROI) within a first tissue type within a body. A control unit drives a measurement unit to provide an operating condition such that acoustic waves overlap with a region within the ROI that is illuminated by illuminating light such as to generate a first set of tagged photons, and such that the acoustic waves overlap with a region of tissue within a second tissue type that is illuminated by illuminating light such as to generate a second set of tagged photons, the first and second sets of tagged photons being distinguishable from one another. The control unit determines the parameter of the ROI by extracting data portions associated with, respectively, the light response of the ROI and the light response of the second tissue type, by distinguishing between the sets of tagged photons. | 07-19-2012 |
20130151188 | METHOD AND SYSTEM FOR NON-INVASIVELY MONITORING FLUID FLOW IN A SUBJECT - A fluid flow monitoring system is provided that has a processor utility which is connectable to an acoustic generator associated with acoustic ports and is operable for generating signals S | 06-13-2013 |
Revital Ramaty, Ramat-Hasharon IL
Patent application number | Description | Published |
---|---|---|
20080287447 | Methods for preparing eszopiclone - Methods for the preparation of crystalline eszopiclone free base in water, in the absence of organic solvents, are provided. The methods are more environmentally acceptable than prior art methods, and produce eszopiclone free base essentially free of residual organic solvent. | 11-20-2008 |
20090221595 | Crystalline form of sitagliptin - A Sitagliptin crystalline form characterized by PXRD pattern having any 5 peaks selected from the group consisting of 7.4, 11.5, 16.7, 17.7, 18.9, 24.1, 24.5, 27.0, 28.5 and 28.8±0.2 degrees 2-theta, wherein any combination of peaks selected includes the peak at 7.4±0.2 degrees two theta, processes for preparing said Sitagliptin crystalline form, and pharmaceutical compositions thereof, are provided. | 09-03-2009 |
20100041885 | CRYSTALLINE FORMS OF SITAGLIPTIN PHOSPHATE - A Sitagliptin phosphate characterized by data selected from the group consisting of: a powder XRD pattern with peaks at 4.7, 13.5, 17.7, 18.3, and 23.7±0.2 degrees two theta; a powder XRD pattern with peaks at about 4.7, 13.5, and 15.5±0.2 degrees two theta and at least another two peaks selected from the following list: 14.0, 14.4, 18.3, 19.2, 19.5 and 23.7±0.2 degrees two theta; and a powder XRD pattern with peaks at about 13.5, 19.2, and 19.5±0.2 degrees two theta and at least another two peaks selected from the following list: 4.7, 14.0, 15.1, 15.5, 18.3, and 18.7±0.2 degrees two theta; a powder XRD pattern with peaks at about 13.5, 15.5, 19.2, 23.7, and 24.4±0.2 degrees two theta; and a powder XRD pattern with peaks at about 4.65, 13.46, 17.63, 18.30, and 23.66±0.10 degrees two theta, processes for preparing said Sitagliptin crystalline form, and pharmaceutical compositions thereof, are provided. | 02-18-2010 |
20100249140 | SOLID STATE FORMS OF SITAGLIPTIN SALTS - Solid state forms of Sitagliptin salts, processes for preparing the solid state forms, and pharmaceutical compositions thereof, are provided. | 09-30-2010 |
20120316175 | SOLID STATE FORMS OF SITAGLIPTIN SALTS - Solid state forms of Sitagliptin salts, processes for preparing the solid state forms, and pharmaceutical compositions thereof, are provided. | 12-13-2012 |
Revital Shani-Hershkovich, Mazkeret Batia IL
Patent application number | Description | Published |
---|---|---|
20120296569 | METHOD AND SYSTEM FOR WEIGHTED ANALYSIS OF NEUROPHYSIOLOGICAL DATA - A method of analyzing neurophysiological data is disclosed. The method comprises: identifying activity-related features in the data, constructing a brain network activity (BNA) pattern having a plurality of nodes, each representing a feature of the activity-related features, and assigning a connectivity weight to each pair of nodes in the BNA pattern. | 11-22-2012 |
Revital Sharivkin, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20150157668 | Methods Of Isolating Distinct Pancreatic Cell Types - Methods of isolating distinct specific cell types within mixed populations of cells. Methods of isolating specific cell types among pancreatic cells, particularly from human islets of Langerhans. Markers and combinations thereof for use in methods of isolating insulin producing islet beta cells for treatment of diabetes. | 06-11-2015 |